300015.SZ vs BILL — which is stronger right now?
Same dated snapshot (2026-09-01): 300015.SZ quality —/100 vs BILL 100/100; engine WAIT vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 300015.SZ (Aier Eye Hospital) | BILL (BILL) | |
| Market / sector | ashare · Healthcare Svcs | us · Technology |
| Price | ¥8.52 | $48.11 |
| Quality score | —/100 | 100/100 |
| Engine signal | WAIT · 31 bars · uPnL +0.0% | LONG · 75 bars · uPnL +15.0% |
| Total return | -33.6% | -22.7% |
Thesis-break template (Healthcare Svcs)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "300015.SZ vs BILL — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/300015.sz-vs-bill · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice